Zurich Cantonal Bank
AVDL

Zurich Cantonal Bank’s Avadel Pharmaceuticals AVDL Stock Holding History

Zurich Cantonal Bank’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-37,707
Closed -$732K – 2647
2025
Q3 		$576K Hold
37,707
– – ﹤0.01% 1659
2025
Q2 		$334K Hold
37,707
– – ﹤0.01% 1891
2025
Q1 		$295K Buy
37,707
+6,246
+20% +$52.3K ﹤0.01% 1896
2024
Q4 		$331K Buy
31,461
+11,448
+57% +$139K ﹤0.01% 1874
2024
Q3 		$262K Buy
+20,013
New +$305K ﹤0.01% 1964
2024
Q2 		– Sell
-19
Closed -$321 – 2649
2024
Q1 		$321 Sell
19
-1,985
-99% -$29.6K ﹤0.01% 2676
2023
Q4 		$28.3K Sell
2,004
-246
-11% -$2.89K ﹤0.01% 2642
2023
Q3 		$23.2K Sell
2,250
-740
-25% -$9.91K ﹤0.01% 2697
2023
Q2 		$49.3K Sell
2,990
-534
-15% -$6.94K ﹤0.01% 2619
2023
Q1 		$32.3K Buy
3,524
+566
+19% +$4.65K ﹤0.01% 2689
2022
Q4 		$21.2K Sell
2,958
-561
-16% -$3.93K ﹤0.01% 2749
2022
Q3 		$18K Sell
3,519
-317
-8% -$1.75K ﹤0.01% 2814
2022
Q2 		$9K Hold
3,836
– – ﹤0.01% 2859
2022
Q1 		$26K Buy
+3,836
New +$26.4K ﹤0.01% 2639

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Zurich Cantonal Bank's AVDL Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 37,707 shares — an estimated $732K sold.

Zurich Cantonal Bank first reported a position in AVDL in Q1 2022 and held it in 14 quarters. The position peaked at $576K in Q3 2025. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 37,707 Avadel Pharmaceuticals shares in Q4 2025, an estimated $732K.
  • Zurich Cantonal Bank first reported a position in Avadel Pharmaceuticals in Q1 2022 and held it in 14 quarters.
  • Zurich Cantonal Bank's Avadel Pharmaceuticals position peaked at $576K in Q3 2025.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.